Dublin, Feb. 26, 2018 -- The "US HIV/AIDS Diagnostics Market Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Suppliers" report has been added to ResearchAndMarkets.com's offering
This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
- Hospitals
- Commercial/Private Laboratories
- Blood Banks
- Physician Offices
- Public Health Laboratories
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.
Highlights
- Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
- Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
- Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
- Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
- Analyzes alternative market penetration strategies for suppliers.
Key Topics Covered:
I. Introduction
II. AIDS/HIV Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. USA: Market Size, Growth and Major Suppliers'
Sales and Market Shares
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatch/Leica
- Life Technology
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako
For more information about this report visit https://www.researchandmarkets.com/research/x6489j/us_hivaids?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing


Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses
South Korea, US Discuss Chip Investments Amid Tariff Plans
Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger
Milei Threatens Falkland Oil Firms With Sanctions
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks
CATL Shares Fall as Hungary Plant Faces Safety Halt
Xiaomi Shares Jump on Europe EV Expansion Plan
OpenAI Nears Astra AI Model Launch With Safety Focus
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations
GSM Eyes US, Europe Expansion Ahead of 2028 Hong Kong IPO
Lynas Rare Earths Shares Rise After Takeover Talks Revealed
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus
Shein Shares Drop 5% After Weak Hong Kong IPO Debut
Anthropic Nears $15 Billion Credit Deal Ahead of IPO 



